Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ALAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD7P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RNF126 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC92 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDGFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF678 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUS3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS37C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRS1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRLF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIN3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GYPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on